Publication
A case study describing a Phase I dose escalation and cohort expansion study of an immune checkpoint inhibitor in patients with advanced solid…
Case Study
A case study describing two Phase II, multicenter studies assessing the efficacy and safety of an autologous cellular therapy treatment.
Blog
Stop—take a breath. Notice it. Notice your body relax. Become aware of where you are. Acknowledge your thoughts, but don’t cling to them. Let them go.
Blog
Social distancing is a new term for us all—and now we hear it every day. According to PRA’s Dr. Greg Licholai, Chief Medical Information Officer,…
Blog
Being cooped up in the house can be challenging when it comes to staying healthy and fit. Staying home leaves more time to start new routines, but…
Blog
With so much uncertainty about the future of our health, economy, and the state of the world, our mental health is put at risk. According to the…
Case Study
PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease…
Fact Sheet
Improving the science of abuse assessment before a drug is marketed is a unified goal for the FDA and pharmaceutical industry. It is the hope that…
Page
How can we keep healthcare affordable and accessible to all? How can we use science to benefit humans? Asking Ewoud-Jan van Hoogdalem a question…
Page
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…